How Biosimilars Are Driving Down the Price of Herceptin
EDINBURGH, UNITED KINGDOM – JUNE 09: A bottle of the drug Herceptin is displayed in the satellite … [+]
Nine to twelve years. That’s about how long most drug companies have to make serious money on new products before their patent protection ends. Then, generic companies enter the fray and prices, typically, plummet.
Herceptin, a drug used to treat breast and stomach cancer, remained priced at over $70,000 per patient for almost two decades after coming to market. So, what kept the price so high for so long, and what caused the recent almost 60% drop in price? The answer is simple: biosimilars!
Unlike common drugs that are small molecules, Herceptin is a monoclonal antibody, a large biologic molecule that cannot be synthesized by a chemist. This complexity in manufacturing made it challenging for generic companies to enter the market even after the patent expired. It took brave companies 6-9 years and over $100 million to bring biosimilar versions of Herceptin, known as trastuzumab, to market.
With no competition, Herceptin brought in over $300 million in annual sales in the US in 2007, 20 years after its launch. However, when several companies successfully manufactured biosimilar versions of the drug, competition increased. Physicians began to trust these biosimilars, leading to a significant drop in prices by as much as 60%.
According to a study conducted by Alice Chen and colleagues at the University of Southern California, the market share of biosimilar competitors for Herceptin grew significantly, leading to a decline in prices:
Growth of biosimilar competition for Herceptin
Another illustration shows the price drop of trastuzumab after the introduction of biosimilar competition:
Dropping prices of trastuzumab
Currently, the price of Herceptin for a patient with “HER2 positive metastatic breast cancer” is around $50,000, a significant decrease from its original price. Biosimilars are even more cost-effective. While it remains an expensive treatment, the increased competition in the healthcare market is driving down the price of this life-saving chemotherapy, making it more accessible to those in need.
The world today is constantly changing and evolving, with new technologies, trends, and ideas shaping how we live our lives. It can be overwhelming to keep up with all the changes happening around us, but one thing is for certain – the future is bright.
One of the most exciting developments in recent years is the rise of artificial intelligence (AI). AI is a branch of computer science that aims to create machines that can perform tasks that would typically require human intelligence, such as reasoning, learning, and problem-solving. This technology has the potential to revolutionize industries across the board, from healthcare and finance to transportation and entertainment.
In healthcare, AI is already being used to improve patient care and outcomes. Machines are now able to analyze medical images, such as X-rays and MRIs, more accurately and quickly than human doctors. This has the potential to revolutionize how diseases are diagnosed and treated, ultimately saving lives.
In the finance industry, AI is being used to detect fraud and predict market trends. By analyzing vast amounts of data, machines can identify patterns and anomalies that humans may overlook, helping to protect consumers and businesses from financial risks.
In transportation, AI is being used to develop self-driving cars and drones that can navigate roads and airspace more efficiently and safely than human drivers. This technology has the potential to reduce traffic congestion, accidents, and emissions, making our cities cleaner and more livable.
In entertainment, AI is being used to create personalized recommendations for movies, music, and books. By analyzing our preferences and behaviors, machines can suggest content that we are likely to enjoy, making it easier for us to discover new and exciting media.
While AI has the potential to bring about many positive changes, it also raises important ethical and societal questions. For example, how do we ensure that AI is used responsibly and ethically? How do we protect the privacy and security of individuals’ data? How do we ensure that AI benefits everyone, not just a privileged few?
As we look to the future, it is important that we continue to ask these questions and engage in thoughtful dialogue about the role of AI in our lives. By working together to harness the potential of this powerful technology, we can create a brighter and more inclusive future for all.
